articleCell MetabolismSep 1, 2013BRONZE OA

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes

GGGregory GaichJYJenny Y. ChienHFHaoda FuLCLeonard C. GlassMAMark A. Deeg

Eli Lilly (United States) · Southwestern Medical Center · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

875
total citations
FWCI
34.55
Percentile
100%
References
42
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Type 2 diabetes
  • FGF21
  • Diabetes mellitus
  • Obesity
  • Medicine
  • Internal medicine
  • Endocrinology
  • Bioinformatics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.